Trastuzumab Completed Phase 3 Trials for Neoplasms, Breast Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01125566LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
NCT00021255Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
NCT00320385Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer